Ursprung des Netzwerks ersten Grades von Rose Lin
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Private Company | Pharmaceuticals: Major | 22 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rose Lin
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| National Taiwan University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
KPCB China Fund II LP
 KPCB China Fund II LP Investment ManagersFinance KPCB China Fund II LP seeks investment opportunities in companies located in China. The fund focuses on companies operating in the fields of health technology, industrial services, and technology services sectors.. It provides financing for seed, early and later-stage capital requirements. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Chime Biologics Ltd.
 Chime Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Chime Biologics Ltd. is a leading Contract Development and Manufacturing Organization (CDMO) that provides customer-centric and cost-effective outsourcing services for biopharmaceutical development and manufacturing. The company is based in Wuhan, China, and its world's first GE Kubio facility is located at Wuhan's Bio-Lake Biotech Industry Development Zone, with a clear path to expand the total capacity up to 140,000+ liters in the near future. The Chinese company has introduced the world's first modular biopharmaceutical plant, Kubio, which empowers its partners' success in biologics from cell line development to commercial manufacturing. Chime Biologics is committed to making cutting-edge biomedicines affordable and accessible to all patients, fulfilling its commitment to human health. Chime Biologics is ISO 14001:2015 and ISO 45001:2018 certified and has been providing customers with clinical materials for pre-clinical and clinical stages worldwide since 2016. | Miscellaneous Commercial Services | Chairman President | |
| ZAI LAB LIMITED | Biotechnology | Founder Chief Executive Officer | |
Development Center for Biotechnology
 Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
| FORESEE PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| Chi-Chi Co. Ltd. | Chairman | ||
| National Tsing-Hua University | College/University | Undergraduate Degree | |
| HUTCHMED (CHINA) LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Hongshan
 Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Investment Managers | Private Equity Investor | |
Zai Venture Partners
 Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Investment Managers | Founder | |
| Jilin University | College/University | Undergraduate Degree | |
| TWI PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
RT-Mart International Ltd.
 RT-Mart International Ltd. Food RetailRetail Trade RT-Mart International Ltd. operates hypermarket stores. The firm provides food and non-food retail services through its hypermarket stores in Taiwan. The company was founded in 1997 and is located in Taipei, Taiwan. | Food Retail | Director/Board Member | |
| University of Missouri | College/University | Graduate Degree | |
Hutchison Whampoa (China) Ltd.
 Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Financial Conglomerates | Corporate Officer/Principal | |
| CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. | Pharmaceuticals: Generic | Director/Board Member | |
Vita Genomics, Inc.
 Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Medical/Nursing Services | Chief Executive Officer | |
| SHAREHOPE MEDICINE CO., LTD. | Medical Distributors | Director/Board Member | |
| AUSTAR LIFESCIENCES LIMITED | Industrial Machinery | Director/Board Member | |
| University of Cincinnati (Ohio) | College/University | Doctorate Degree | |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Medical Specialties | Chief Executive Officer | |
| HAKERS ENTERPRISE CO., LTD. | Apparel/Footwear | Director/Board Member | |
| PHARMIGENE, INC. | Pharmaceuticals: Generic | Director/Board Member | |
| Yuan He Biotech Co. Ltd. | Director/Board Member | ||
| Chenergy Co. Ltd. | Director/Board Member | ||
| National University | College/University | Masters Business Admin | |
| HO TUNG CHEMICAL CORP. | Chemicals: Specialty | Director/Board Member | |
| POLARIS GROUP | Biotechnology | Director/Board Member | |
| Yurun Merit Biotech (Lianyungang) Co. Ltd. | Director/Board Member | ||
Shanghai GeneCore BioTechnologies Co., Ltd.
 Shanghai GeneCore BioTechnologies Co., Ltd. BiotechnologyHealth Technology Part of Quest Diagnostics, Inc., Shanghai GeneCore BioTechnologies Co., Ltd. engages in nucleotide synthesis, DNA sequencing, bioinformatics analysis, and mutation detection. The company is based in Shanghai, China. | Biotechnology | Director/Board Member | |
| MERIT BIOTECH INC | Pharmaceuticals: Major | Chairman | |
| Chia-Ho Co., Ltd. | Chairman | ||
Chia He Investment Co. Ltd.
 Chia He Investment Co. Ltd. Financial ConglomeratesFinance Chia He Investment Co. Ltd. operates as an investment holding Taiwanese company. | Financial Conglomerates | Chairman | |
| Ya Tung Investment Co. Ltd. | Director/Board Member | ||
| Merit Ocean Biotech, Inc. | Chairman | ||
| University of California | College/University | Undergraduate Degree | |
| Shandong Medical University | College/University | Undergraduate Degree | |
| Syracuse University | College/University | Doctorate Degree | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ANAPTYSBIO, INC. | Biotechnology | Corporate Officer/Principal | |
| SYNTHORX, INC. | Biotechnology | Corporate Officer/Principal | |
| DENALI THERAPEUTICS INC. | Biotechnology | Corporate Officer/Principal | |
| University of Vienna | College/University | Doctorate Degree | |
| University of British Columbia | College/University | Doctorate Degree |
Statistik
International
| Taiwan | 22 |
| Vereinigte Staaten | 15 |
| China | 10 |
| Cayman Islands | 3 |
| Hong Kong | 3 |
Sektoral
| Health Technology | 19 |
| Consumer Services | 13 |
| Finance | 6 |
| Health Services | 3 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 74 |
| Corporate Officer/Principal | 34 |
| Chairman | 19 |
| Independent Dir/Board Member | 13 |
| Undergraduate Degree | 13 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Zuie Chin Huang | 40 |
| Yi Hsiung Chen | 24 |
| Bryant Fong | 23 |
| Max Chan | 16 |
| Chia Lin Wang | 10 |
| Ying Du | 9 |
| Charles Winter | 8 |
| Ellis Chu | 8 |
| Ta Cheng Hsu | 7 |
| Jun Wu | 7 |
| Chien Chung Wei | 5 |
| Raco Ivan Jordanov | 5 |
| Rong Chen | 4 |
| DJ Lin | 3 |
| Meng Ting Chen | 2 |
